Table 2 Accuracies of the stepwise greedy forward selections for selecting marker genes for primary cancers (column 2) and their ability for predicting metastatic cancer types (column 3) and discriminating primary from metastatic cancers (column 4)
Number of top genes | 6-way prediction (primary cancers; 1-NN) | 6-way prediction (metastatic cancers; 1-NN) | Classification of primary and metastatic cancers (GNB) |
|---|---|---|---|
10 | 78.64 | 37.4 | 88.35 |
20 | 80.74 | 38.11 | 95.22 |
30 | 81.61 | 37.58 | 92.87 |
40 | 81.8 | 38.12 | 93.13 |
50 | 81.8 | 37.29 | 93.55 |
100 | 82.38 | 37.51 | 93.28 |
150 | 82.23 | 37.08 | 94.38 |
200 | 82.1 | 37.36 | 95.1 |